Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: the experience of a single institution with 269 patients (stone-01)

HIGHLIGHTS

• who: Michele Fiore and colleagues from the Department of Radiation Oncology, Campus Bio-Medico University, Rome, Italy have published the paper: Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01), in the Journal: Cancers 2021, x of 21/08/2019
• what: The aim of this study was to define a potential benefit of pathological complete response rate (pCR) and downstaging rate after neoadjuvant chemoradiotherapy (CRT) in relation to treatment and patient factors in locally advanced rectal cancer.
• future: Prospective studies are . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.